Paper19821824
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
Taylor CM and 4 others. Br J Haematol, 2010. Cited by 148 papers, by iCite.
Cite this record
ConductScience Library. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Papers, record 19821824. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19821824
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemolytic-Uremic Syndrome | Major topic |
| Antibodies, Monoclonal | |
| Antibodies, Monoclonal, Humanized | |
| Clinical Trials as Topic | |
| Humans | |
| Kidney Transplantation | |
| Liver Transplantation | |
| Plasma Exchange | |
| Terminology as Topic |
Source PubMed
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 148 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42866244 | Excellent Response to Eculizumab in a Patient With Complement-Mediated Thrombotic Microangiopathy and a Novel Plasminogen Gene Variant. | Case Rep Hematol | 2026 | https://conductscience.org/library/papers/42866244 | PubMed |
| 42694968 | Comparative Analysis of Clinicopathological Features and Outcomes Between Kidney-Limited and Systemic Thrombotic Microangiopathy: A Study Based on a Semiquantitative Pathological Scoring System. | Int J Nephrol Renovasc Dis | 2026 | https://conductscience.org/library/papers/42694968 | PubMed |
| 40352901 | Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome. | Indian J Nephrol | 2025 | https://conductscience.org/library/papers/40352901 | PubMed |
| 39676096 | Extrarenal manifestations of atypical hemolytic uremic syndrome: a systematic review and meta-analysis. | Pediatr Res | 2025 | https://conductscience.org/library/papers/39676096 | PubMed |
| 38779250 | A Rare Case of Atypical Hemolytic Uremic Syndrome (aHUS) Precipitated by Dengue and the Treatment Landscape in Singapore. | Cureus | 2024 | https://conductscience.org/library/papers/38779250 | PubMed |
| 38274833 | Rational use of eculizumab in secondary atypical hemolytic uremic syndrome. | Front Immunol | 2023 | https://conductscience.org/library/papers/38274833 | PubMed |
| 37563792 | New findings in preventing recurrence and improving renal function in AHUS patients after renal transplantation treated with eculizumab: a systemic review and meta-analyses. | Ren Fail | 2023 | https://conductscience.org/library/papers/37563792 | PubMed |
| 37145269 | Atypical HUS with multiple complement system mutations triggered by synthetic psychoactive drug abuse: a case report. | J Nephrol | 2023 | https://conductscience.org/library/papers/37145269 | PubMed |
| 36637720 | Pharmacological Management of Atypical Hemolytic Uremic Syndrome in Pediatric Patients: Current and Future. | Paediatr Drugs | 2023 | https://conductscience.org/library/papers/36637720 | PubMed |
| 36628001 | Trends and Outcomes of Hospitalizations Due to Hemolytic Uremic Syndrome: A National Perspective. | Cureus | 2022 | https://conductscience.org/library/papers/36628001 | PubMed |
| 36369988 | Kidney diseases. | Immunol Rev | 2023 | https://conductscience.org/library/papers/36369988 | PubMed |
| 36147129 | Two concomitant thrombotic microangiopathies in the background of systemic lupus erythematosus: A case report. | Ann Med Surg (Lond) | 2022 | https://conductscience.org/library/papers/36147129 | PubMed |
| 35109910 | Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists. | Orphanet J Rare Dis | 2022 | https://conductscience.org/library/papers/35109910 | PubMed |
| 33783815 | Interventions for atypical haemolytic uraemic syndrome. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/33783815 | PubMed |
| 33516177 | Occlusive retinal vasculopathy with macular branch retinal artery occlusion as a leading sign of atypical hemolytic uremic syndrome - a case report. | BMC Ophthalmol | 2021 | https://conductscience.org/library/papers/33516177 | PubMed |
| 33512445 | How I treat microangiopathic hemolytic anemia in patients with cancer. | Blood | 2021 | https://conductscience.org/library/papers/33512445 | PubMed |
| 33427983 | A rare cause of recurrent acute kidney injury in a 3-year-old girl: Answers. | Pediatr Nephrol | 2021 | https://conductscience.org/library/papers/33427983 | PubMed |
| 32968372 | Hemolytic Uremic syndrome associated with pregnancy: Outcome from acute Kidney Injury. | Pak J Med Sci | 2020 | https://conductscience.org/library/papers/32968372 | PubMed |
| 32322437 | Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis. | Exp Hematol Oncol | 2020 | https://conductscience.org/library/papers/32322437 | PubMed |
| 31516771 | An Unusual Case of Diffuse Alveolar Hemorrhage as a Clinical Manifestation of Atypical Hemolytic Uremic Syndrome: A Case Report. | Cureus | 2019 | https://conductscience.org/library/papers/31516771 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19821824
GET https://conductscience.org/api/papers/v1/19821824/cited_by?page=2